C. Cristofol et al., DISPOSITION OF NETOBIMIN, ALBENDAZOLE, AND ITS METABOLITES IN THE PREGNANT RAT - DEVELOPMENTAL TOXICITY, Toxicology and applied pharmacology, 144(1), 1997, pp. 56-61
Netobimin (NTB), a benzimidazole prodrug with a goad anthelmintic spec
trum, was administered orally to female rats at a dose of 59.5 mg NTB/
kg, to study its pharmacokinetic behavior and the disposition of its m
ost important metabolites, albendazole (ABZ), albendazole sulfoxide (A
BZSO), and albendazole sulfone (ABZSO,). ABZ was found in plasma after
6 hr. Peak plasma concentrations (C-max) and areas under curves (AUG)
of ABZSO were eight- and fourfold higher, respectively, than those of
ABZSO(2). To study NTB disposition in pregnant rats, three different
drug doses (50, 59.5, and 70.7 mg/kg) were given. No significant diffe
rences were found between plasma concentrations for each metabolite at
the three doses studied. Only ABZ concentrations rose slightly as clo
se increased. ABZ, ABZSO, and ABZSO(2) were found in amniotic sacs and
embryos at concentrations that were higher than plasma at the same ti
mes. The fetuses obtained after administration of each of the doses of
NTB were studied to detect developmental toxicity. A significant corr
elation was found between rate of developmental toxicity and metabolit
e concentration, ABZSO embryo concentrations could be the main factor
accounting for toxicity. (C) 1997 Academic Press.